Oceania Healthcare reports strong interim growth, operational efficiency

Oceania Healthcare reported Proforma Underlying EBITDA of $41.8m for the six months ended September 30, 2025, a 20% increase from the prior comparative period. Reported Total Comprehensive Income surged by 241% to $40.4m, while Operating Cash Flow rose 12% to $79.0m. Total assets reached $3.0bn, consistent with March 2025 figures.

Operational highlights include 271 total sales, a 5% increase year-on-year, with care occupancy at 94.7% (excluding development sites), up 0.2% from March 2025. The company completed 40 units and care suites in 1HY26, with 31 additional units expected in FY26. Annualised Care EBITDA per bed, excluding resale gains, increased by 45.5% to $12,400, reflecting improved care margins and reduced overhead costs.

Strategic initiatives, including sales performance, business excellence, and capital management, have driven positive momentum, resulting in a reduction of the debt gearing ratio to 34.8%, now within the targeted range of 30-35%. The company continues to focus on developing high-quality care and retirement living, with strong demographic demand outstripping supply in key markets.